| Ticker: | LEXX |
| Current Price: | $2.82 |
| % Daily Change: | 0.71% |
| Volume (1,000s): | 103.88 |
| Average Volume (1,000s): | 109.49 |
| Market Cap (M): | $4.66 |
| 1/2/2024 Price: | $2.11 |
| Change Since Inception: | 33.65% |
Lexaria Bioscience Corp.
740 McCurdy Road
Suite 100
Kelowna, BC V1X 2P7
Canada
Lexaria Bioscience Corp.’s patented drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio and many patents pending worldwide.